Incyte | Le Coût Des Ventes



Cost Of Sales Changement Date
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amgen USD 2.6B 507M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Exelixis USD 19.17M 793K 2025-04
Gilead Sciences USD 1.54B 41M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Incyte Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.